[Effect of antiplasmin preparations and heparin on experimentally induced intravascular coagulation (author's transl)].
D000818:Animals; D007611:Aprotinin / Q000627:therapeutic use*; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use*; D004211:Disseminated Intravascular Coagulation / Q000188:drug therapy*; D005341:Fibrinolysin / Q000037:antagonists & inhibitors*; D006493:Heparin / Q000627:therapeutic use*; D008744:Methylamines / Q000627:therapeutic use; D011817:Rabbits
D003509:Cyclohexanecarboxylic Acids; D008744:Methylamines; D006493:Heparin; D007611:Aprotinin; D005341:Fibrinolysin